Identification of de novo mutations of Duchénnè/Becker muscular dystrophies in southern Spain

Int J Med Sci. 2014 Jul 17;11(10):988-93. doi: 10.7150/ijms.8391. eCollection 2014.

Abstract

Background: Duchénnè/Becker muscular dystrophies (DMD/BMD) are X-linked diseases, which are caused by a de novo gene mutation in one-third of affected males. The study objectives were to determine the incidence of DMD/BMD in Andalusia (Spain) and to establish the percentage of affected males in whom a de novo gene mutation was responsible.

Methods: Multiplex ligation-dependent probe amplification (MLPA) technology was applied to determine the incidence of DMD/BMD in 84 males with suspicion of the disease and 106 female relatives.

Results: Dystrophin gene exon deletion (89.5%) or duplication (10.5%) was detected in 38 of the 84 males by MLPA technology; de novo mutations account for 4 (16.7%) of the 24 mother-son pairs studied.

Conclusions: MLPA technology is adequate for the molecular diagnosis of DMD/BMD and establishes whether the mother carries the molecular alteration responsible for the disease, a highly relevant issue for genetic counseling.

Keywords: Duchénnè/Becker; Multiplex Ligation-dependent Probe Amplification (MLPA); de novo mutations..

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Dystrophin / genetics
  • Exons / genetics
  • Female
  • Gene Deletion
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Muscular Dystrophy, Duchenne / genetics*
  • Mutation
  • Spain
  • Young Adult

Substances

  • Dystrophin